TRAIL Mediated Signaling in Pancreatic Cancer

Nogueira, Daniele Rubert; Yaylim, Ilhan; Aamir, Qurratulain; Kahraman, OzlemTimirci; Fayyaz, Sundas; Naqvi, Syed Kamran-Ul-Hassan; Farooqi, Ammad Ahmad

추천

검색

자료유형: 학술저널

저자정보: Nogueira, Daniele Rubert (Department of Industrial Pharmacy, Health Science Center, Federal University of Santa Maria) Yaylim, Ilhan (Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University) Aamir, Qurratulain (Department of Anatomy, Rashid Latif Medical College) Kahraman, OzlemTimirci (Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University) Fayyaz, Sundas (Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College) Naqvi, Syed Kamran-Ul-Hassan (COMSATS Institute of Information Technology) Farooqi, Ammad Ahmad (Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제15호

발행연도: 2014.1

수록면: 5,977 - 5,982 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Research over the years has progressively shown substantial broadening of the tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL)-mediated signaling landscape. Increasingly it is being realized that pancreatic cancer is a multifaceted and genomically complex disease. Suppression of tumor suppressors, overexpression of oncogenes, epigenetic silencing, and loss of apoptosis are some of the extensively studied underlying mechanisms. Rapidly accumulating in vitro and in vivo evidence has started to shed light on the resistance mechanisms in pancreatic cancer cells. More interestingly a recent research has opened new horizons of miRNA regulation by DR5 in pancreatic cancer cells. It has been shown that DR5 interacts with the core microprocessor components Drosha and DGCR8, thus impairing processing of primary let-7. Xenografting DR5 silenced pancreatic cancer cells in SCID-mice indicated that there was notable suppression of tumor growth. There is a paradigm shift in our current understanding of TRAIL mediated signaling in pancreatic cancer cells that is now adding new layers of concepts into the existing scientific evidence. In this review we have attempted to provide an overview of recent advances in TRAIL mediated signaling in pancreatic cancer as evidenced by findings of in vitro and in vivo analyses. Furthermore, we discuss nanotechnological advances with emphasis on PEG-TRAIL and four-arm PEG cross-linked hyaluronic acid (HA) hydrogels to improve availability of TRAIL at target sites.

#Pancreatic cancer #TRAIL #apoptosis #nanotechnology

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Nogueira, Daniele Rubert

소속기관 Departamento de Farmacia Industrial, Centro de Ciencias da Saude, Universidade Federal de Santa Mari